Should patients be allowed to veto their participation in clinical research?

Patients participating in the shared benefits of publicly funded health care enjoy the benefits of treatments tested on previous patients. Future patients similarly depend on treatments tested on present patients. Since properly designed research assumes that the treatments being studied are—so far...

Full description

Saved in:  
Bibliographic Details
Main Author: Evans, H. M. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2004
In: Journal of medical ethics
Year: 2004, Volume: 30, Issue: 2, Pages: 198-203
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 1816126306
003 DE-627
005 20230427025727.0
007 cr uuu---uuuuu
008 220908s2004 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme.2003.002444  |2 doi 
035 |a (DE-627)1816126306 
035 |a (DE-599)KXP1816126306 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Evans, H. M.  |e VerfasserIn  |4 aut 
245 1 0 |a Should patients be allowed to veto their participation in clinical research? 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Patients participating in the shared benefits of publicly funded health care enjoy the benefits of treatments tested on previous patients. Future patients similarly depend on treatments tested on present patients. Since properly designed research assumes that the treatments being studied are—so far as is known at the outset—equivalent in therapeutic value, no one is clinically disadvantaged merely by taking part in research, provided the research involves administering active treatments to all participants. This paper argues that, because no other practical or moral considerations count decisively against so doing, we could and should oblige patients to agree to receive indicated treatment within the terms of any concurrent research protocols. This ensures their treatment will benefit not only themselves but also future patients through contributing to new knowledge. By analogy with the paying of income tax, patients should not be allowed to “veto” their social responsibility to take part in clinical research. 
601 |a Patient 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 30(2004), 2, Seite 198-203  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:30  |g year:2004  |g number:2  |g pages:198-203 
856 |3 Volltext  |u http://www.jstor.org/stable/27719176  |x JSTOR 
856 |u https://jme.bmj.com/content/medethics/30/2/198.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via free pdf)] 
856 4 0 |u https://doi.org/10.1136/jme.2003.002444  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/30/2/198.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
936 u w |d 30  |j 2004  |e 2  |h 198-203 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185580150 
LOK |0 003 DE-627 
LOK |0 004 1816126306 
LOK |0 005 20220908053356 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-02#2A5499E49AFC392DA4F07C6E187DD9C9DFC1892F 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/27719176 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw